Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression

(2023) Margot F. van Spronsen et al.   LEUKEMIA

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data

(2022) Daniel A. Arber et al.   BLOOD

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

(2022) Joseph D. Khoury et al.   LEUKEMIA

Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group

(2022) Wolfgang Kern et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Flow Cytometric Findings in Clonal Cytopenia of Undetermined Significance

(2021) Priyatharsini Nirmalanantham et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?

(2021) Romane Joudinaud et al.   Frontiers in Oncology

Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet

(2021) Vincent H. J. Velden et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy

(2020) Afshin Shameli et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Low-Grade Myelodysplastic Syndromes With Preserved CD34+ B-Cell Precursors (CD34+ Hematogones)

(2019) Zhining Chen et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

CD177 Enhances the Detection of Myelodysplastic Syndrome by Flow Cytometry

(2019) Khaled Alayed et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome

(2018) Keiko Sasada et al.   LEUKEMIA RESEARCH

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes

(2018) Benjamin N. Ostendorf et al.   PLoS One

The current approach to the diagnosis of myelodysplastic syndromes ☆

(2018) Olga K. Weinberg et al.   SEMINARS IN HEMATOLOGY

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

(2016) Eline M.P. Cremers et al.   HAEMATOLOGICA

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

(2016) Theresia M. Westers et al.   HAEMATOLOGICA

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

(2016) Eline M.P. Cremers et al.   HAEMATOLOGICA

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

(2016) Theresia M. Westers et al.   HAEMATOLOGICA

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

(2015) L. Malcovati et al.   BLOOD

Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations

(2015) Canan Alhan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2015) V. Bardet et al.   HAEMATOLOGICA

The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

(2015) C Alhan et al.   LEUKEMIA

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2015) V. Bardet et al.   HAEMATOLOGICA

Loss of Blast Heterogeneity in Myelodysplastic Syndrome and Other Chronic Myeloid Neoplasms

(2014) Dragan Jevremovic et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

(2014) Patricia Font et al.   ANNALS OF HEMATOLOGY

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes

(2014) Canan Alhan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring

(2014) U. Oelschlaegel et al.   HAEMATOLOGICA

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

(2014) A Porwit et al.   LEUKEMIA

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes

(2014) Feng Xu et al.   PLoS One

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

(2013) S Mathis et al.   LEUKEMIA

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

(2013) T Haferlach et al.   LEUKEMIA

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

(2012) B. Will et al.   BLOOD

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome

(2010) Wolfgang Kern et al.   CANCER

Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment

(2009) T. M. Westers et al.   BLOOD

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: Emphasis on a global evaluation and recognition of diagnostic pitfalls

(2007) Dariusz Stachurski et al.   LEUKEMIA RESEARCH